Jiale Zhang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Transcription Factor

Prostate Cancer

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer. Molecular cancer therapeutics 22 (3) (2023)
Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer. Molecular cancer therapeutics 22 (3) (2023)
Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Nifuroxazide activates the parthanatos to overcome TMPRSS2：ERG fusion-positive prostate cancer. Molecular cancer therapeutics (2023)
Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer. Molecular cancer therapeutics 22 (3) (2023)
Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer. Molecular cancer therapeutics 22 (3) (2023)